Document Detail


Chronic Metformin Treatment is Associated with Reduced Myocardial Infarct Size in Diabetic Patients with ST-segment Elevation Myocardial Infarction.
MedLine Citation:
PMID:  24292206     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: Increased myocardial infarct (MI) size is associated with higher risk of developing left ventricular dysfunction, heart failure and mortality. Experimental studies have suggested that metformin treatment reduces MI size after induced ischaemia but human data is lacking. We aimed to investigate the effect of metformin on MI size in patients presenting with an acute MI.
METHODS: All consecutive patients (n = 3,288) presenting to our hospital with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI between January 2004 and December 2010 were included in this retrospective analysis. Patients with diabetes were divided according to metformin versus non-metformin based pharmacotherapy. MI size was estimated using peak values of serum creatine kinase (CK), myocardial band of CK (CK-MB), and troponin-T.
RESULTS: We identified 677 (20.6 %) patients with diabetes, of whom 189 (27.9 %) were treated with metformin. Chronic metformin treatment was associated with lower peak levels of CK (1,101 vs. 1,422 U/L, P = 0.005), CK-MB (152 vs. 182 U/L, P = 0.018) and troponin-T (2.5 vs. 4.0 ng/L, P = 0.021) compared to non-metformin using diabetics. After adjustment for age, sex, TIMI flow post PCI, and previous MI, the use of metformin treatment remained an independent predictor of smaller MI size. Patient with diabetes treated with metformin had even smaller MI size than patients without diabetes.
CONCLUSIONS: Chronic metformin treatment is associated with reduced MI size compared to non-metformin based strategies in diabetic patients presenting with STEMI. Metformin might have additional beneficial effects beyond glucose lowering efficacy.
Authors:
Chris P H Lexis; Wouter G Wieringa; Bart Hiemstra; Vincent M van Deursen; Erik Lipsic; Pim van der Harst; Dirk J van Veldhuisen; Iwan C C van der Horst
Related Documents :
18005956 - Myocardium at the base of the aorta and pulmonary trunk is prefigured in the outflow tr...
3623196 - Statistical methods for growth allometric studies.
14991706 - Angiopoietin 1 expression levels in the myocardium direct coronary vessel development.
12096946 - Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of m...
17612666 - Influence of left bundle branch block on left ventricular volumes, ejection fraction an...
18563326 - Evaluation of myocardial viability after myocardial infarction with intravenous real-ti...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-12-1
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  -     ISSN:  1573-7241     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  2013 Dec 
Date Detail:
Created Date:  2013-12-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Cardiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, PO Box 30.001, Groningen, The Netherlands, c.p.h.lexis@umcg.nl.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A pumilio homolog in Polycelis sp.
Next Document:  Diosgenin-induced cognitive enhancement in normal mice is mediated by 1,25D3-MARRS.